Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Internal Medicine (Tokyo, Japan)|August 28, 2024
Interleukin-6 Immunology in Macrophage Activation Syndrome Related to Neuroimmunological DiseasesTaichi Nomura, Masaaki Niino, Toshio Odani, et al.Modern Rheumatology|December 19, 2017
Autologous haematopoietic stem cell transplantation for Japanese patients with systemic sclerosis: Long-term follow-up on a phase II trial and treatment-related fatal cardiomyopathyHiroyuki Nakamura, Toshio Odani, Shinsuke Yasuda, et al.Rheumatology (Oxford, England)|April 26, 2014
The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositisTakashi Kurita, Shinsuke Yasuda, Koji Oba, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 18, 2023
Calcium channel blockers may reduce the development of long COVID in femalesTakuya Ozawa, Ryusei Kimura, Hideki Terai, et al.Scientific Reports|September 17, 2020
LAMP3 induces apoptosis and autoantigen release in Sjögren's syndrome patientsTsutomu Tanaka, Blake M Warner, Toshio Odani, et al.Arthritis Research & Therapy|January 20, 2017
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trialMasako Utsunomiya, Hiroaki Dobashi, Toshio Odani, et al.Rheumatology Advances in Practice|November 2, 2020
An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-upMasako Utsunomiya, Hiroaki Dobashi, Toshio Odani, et al.BMJ Open Respiratory Research|December 25, 2024
Long COVID among the first three waves of COVID-19 in Japan: a multicentre cohort studyHatsuyo Takaoka, Ichiro Kawada, Gaku Hiruma, et al.The Journal of Clinical Investigation|February 3, 2022
Lysosomal exocytosis of HSP70 stimulates monocytic BMP6 expression in Sjögren's syndromeYing-Qian Mo, Hiroyuki Nakamura, Tsutomu Tanaka, et al.Vaccine: X|September 21, 2023
Longitudinal long COVID symptoms in Japanese patients after COVID-19 vaccinationsKensuke Nakagawara, Atsuho Morita, Ho Namkoong, et al.Pageof 3